Sociedad Española de Diabetes

What Sociedad Española de Diabetes does

Sociedad Española de Diabetes (SED) is a Spanish nonprofit scientific association headquartered in Madrid, founded in 1954, that serves as the national professional society for diabetes care and research. Its primary members are healthcare professionals—endocrinologists, primary care physicians, residents, nurses, and researchers involved in diabetes management—with secondary outreach to patients with diabetes in Spain. The society is governed by a Junta Directiva and operates a small administrative staff of under 10 people, with a wholly-owned charitable subsidiary, Fundación SED, that runs awareness activities including World Diabetes Day.

SED's core offerings span publications (the peer-reviewed journal Endocrinología, Diabetes y Nutrición published with Elsevier, and the outreach magazine Revista Diabetes reaching its 99th issue in 2026), educational programming (Cursos SED, the FSED congress, and specialized courses for residents and primary care), and digital infrastructure (the SED TV video platform, web-based clinical calculators, RedCAP clinical research registries, and a growing library of clinical guidelines and consensus documents). The society maintains 15 specialized working groups covering areas such as digital diabetes, cardiovascular disease, diabetic foot, therapeutic education, epidemiology, and genetics. Technology is not proprietary beyond web and video platforms; RedCAP is a third-party tool used for clinical data capture. No AI/ML capabilities are evidenced.

SED's business model combines recurring membership fees from individual healthcare professionals with industry collaborations, including 'Socios estratégicos' partnerships with Abbott, Dexcom, Novo Nordisk, and Sanofi, and 'Entidades colaboradoras' agreements with Menarini, MSD, and others. Cross-society collaborations with SEEN, SEMERGEN, SEMFyC, SEMG, and FEDE extend its influence across endocrinology and primary care. Distribution is predominantly domestic (Spain), multi-channel (website, social media, email, SED TV, in-person congresses and courses), and content-led, with no public API, no mobile app, and no disclosed pricing for membership.

Name

Sociedad Española de Diabetes

Legal name

SOCIEDAD ESPAÑOLA DE DIABETES

Website

https://sediabetes.org

Company type

Private

Founded year

1954

Operating status

Operating

Headcount range

1–10 employees

Short description

Sociedad Española de Diabetes (SED) is the national scientific society for diabetes in Spain, serving endocrinologists, primary care physicians, nurses, and researchers through clinical guidelines, peer-reviewed publications (EDN journal, Revista Diabetes), the SED TV platform, congresses, and 15 specialized working groups, with industry partnerships funding its operations.

Ownership category

akta.pro rank

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Membership fees: Annual membership fees from healthcare professional members including endocrinologists, physicians, nurses, and other diabetes specialists
2. Industry collaborations: Partnerships with pharmaceutical and medical device companies for educational activities and research

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Sociedad Española de Diabetes (SED) is a nonprofit scientific association that advances diabetes care in Spain by producing clinical guidelines and consensus documents, publishing peer-reviewed journals (Revista Diabetes, Revista EDN), delivering continuing medical education through congresses and structured courses, maintaining a video content platform (SED TV), operating clinical research registries (RedCAP), and providing clinical decision-support calculators for healthcare professionals. It coordinates 15 specialized working groups spanning areas from digital diabetes and diabetes technology to cardiovascular disease and diabetic foot care.

Product overview

Sociedad Española de Diabetes (SED) operates as a scientific society offering a portfolio of professional development and patient education resources. The core offerings include scientific publications (Revista Diabetes, Revista EDN), a video content platform (SED TV) with webinars and congress recordings, clinical tools (Calculadoras), and structured educational programs (Cursos SED). Research capabilities are supported through RedCAP registries. Patient-facing resources include educational materials and the Fundación SED foundation for awareness activities. The organization also maintains specialized working groups covering diabetes technology, therapeutic education, and related clinical areas.

Differentiator

Problem solved

Functional benefit

Brands

• Fundación SED: Charitable foundation of the Sociedad Española de Diabetes, focused on diabetes awareness, World Diabetes Day activities, and patient support initiatives.
• SED TV
• Revista Diabetes

Products and services

• Revista Diabetes Outreach magazine of SED covering scientific, healthcare, and technological challenges in diabetes, reaching its 99th issue in 2026. Distributed to members and available to the wider diabetes community.
• Revista EDN (Endocrinología, Diabetes y Nutrición) Scientific journal published in collaboration with Elsevier covering endocrinology, diabetes, and nutrition topics, providing peer-reviewed content for clinicians and researchers.
• SED TV Digital video platform hosting webinars, congress recordings, courses, and educational videos for diabetes professionals and patients.
• Calculadoras (Clinical Calculators) Online calculators for healthcare professionals to support clinical decision-making in diabetes management.
• Cursos SED Continuing medical education courses for healthcare professionals covering diabetes diagnosis, treatment, and management, including specialized courses for residents and hybrid-format programs.
• Registros RedCAP Clinical research registries using the RedCAP platform for structured data collection in diabetes studies.
• Publicaciones SED (Clinical Guidelines) Clinical guidelines and consensus documents published by SED, including the 2026 Guía de Uso de Sistemas de Monitorización Continua de Glucosa and consensus documents on continuous glucose monitoring in type 2 diabetes.
• Materiales para Pacientes Educational materials including infographics, videos, and PDFs on diabetes management, injection techniques, oral health, and lifestyle for patients with diabetes.

Quantifiable outcome

• More than 50% of people with diabetes in Spain have lost some dental piece; more than 66% present or have been diagnosed with periodontitis (from oral health report)

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered collaborating and strategic.

• Donte GroupcollaboratingStrategic or Co-development Partner · 27 June 2026Collaborated on the report 'Oral health and diabetes: a bidirectional relationship with social, health and economic impact'. The report received the endorsement (aval) of SED and FEDE.
• AbbottstrategicStrategic or Co-development PartnerStrategic partner (Socio estratégico) of SED for diabetes technologies and products. Abbott provides diabetes monitoring solutions including FreeStyle Libre glucose monitoring systems.
• DexcomstrategicStrategic or Co-development PartnerStrategic partner (Socio estratégico) of SED. Dexcom provides continuous glucose monitoring (CGM) technology solutions.
• Novo NordiskstrategicStrategic or Co-development PartnerStrategic partner (Socio estratégico) of SED. Novo Nordisk is a pharmaceutical company focused on diabetes treatments including insulin and GLP-1 therapies. Collaborated on educational video content.
• SanofistrategicStrategic or Co-development PartnerStrategic partner (Socio estratégico) of SED. Sanofi provides pharmaceutical products and collaborates on diabetes education initiatives.
• MenarinicollaboratingStrategic or Co-development PartnerCollaborating entity (Entidad colaboradora) of SED. Menarini is a pharmaceutical company involved in diabetes care.
• MSDcollaboratingStrategic or Co-development PartnerCollaborating entity (Entidad colaboradora) of SED. MSD (Merck & Co.) is a pharmaceutical company involved in diabetes treatments.
• Federación Española de Diabetes (FEDE)collaboratingStrategic or Co-development PartnerPatient federation providing endorsement for joint initiatives. FEDE represents diabetes patient associations across Spain.
• Sociedad Española de Endocrinología y Nutrición (SEEN)collaboratingStrategic or Co-development PartnerMedical society collaborating on consensus documents for diabetes care guidelines.
• SEMERGEN, SEMFyC, SEMGcollaboratingStrategic or Co-development PartnerPrimary care medical societies collaborating on consensus documents regarding continuous glucose monitoring use in type 2 diabetes.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• International Diabetes Federation (IDF): Global umbrella federation of national diabetes associations. Comparable mission around diabetes research, education, guidelines (e.g., IDF Atlas), World Diabetes Day, and advocacy — paralleling SED's role at the international level.
• Diabetes UK: UK national charity for diabetes. Comparable in delivering professional guidelines, research funding, patient information, advocacy, and awareness campaigns for healthcare professionals and patients within a single country — a structural twin to SED.
• Sociedad Española de Endocrinología y Nutrición (SEEN): Spanish endocrinology and nutrition society, co-author of multiple SED consensus documents. Closest Spanish peer, overlapping heavily on clinician membership, guidelines, and congresses in the diabetes and metabolism space.
• American Diabetes Association (ADA): National diabetes scientific society in the United States. Closely comparable in mission and operating model: clinical guidelines, professional education, peer-reviewed journals, congresses, advocacy, and patient resources for healthcare professionals and people with diabetes.
• European Association for the Study of Diabetes (EASD): European-level scientific society for diabetes. Comparable as a membership organization that delivers annual congresses, publishes the Diabetologia journal, produces clinical guidance, and supports research grants for diabetes professionals across multiple countries.

Regional players

• Sociedade Portuguesa de Diabetologia (SPD): Portuguese national diabetes scientific society. Direct functional peer (clinical guidance, education, congresses, working groups) operating in the neighboring Iberian market rather than competing in Spain.
• Fédération Française des Diabétiques (AFD): French national federation of diabetes patient associations. Comparable patient-education, awareness, and advocacy mandate; operates across a different national market and is patient-led rather than clinically led like SED.

Emerging players

• RedGDPS (Red de Grupos de Estudio de la Diabetes en Atención Primaria): Network of Spanish primary care diabetes study groups. Partial overlap as another Spanish organization producing diabetes guidance and education, but focused on primary care physicians rather than the specialist endocrinologist base of SED.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/SEDiabetes
• YouTubeyoutube.com/c/SociedadEspa%C3%B1oladeDiabetes
• Facebookfacebook.com/SEDiabetes
• LinkedInes.linkedin.com/company/sociedad-espa%C3%B1ola-de-diabetes
• Instagraminstagram.com/sediabetes/?hl=es

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sociedad Española de Diabetes